Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 1
1983 1
1987 1
1990 2
1991 1
1992 1
1993 2
1994 3
1995 2
1996 1
1997 2
1998 1
1999 1
2000 1
2002 1
2003 5
2004 4
2005 4
2006 5
2007 1
2008 3
2009 1
2010 1
2011 3
2012 3
2013 1
2014 3
2015 4
2016 6
2017 4
2019 3
2020 4
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

80 results
Results by year
Filters applied: . Clear all
Page 1
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.
Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA. Lynch TJ, et al. Among authors: okimoto ra. N Engl J Med. 2004 May 20;350(21):2129-39. doi: 10.1056/NEJMoa040938. Epub 2004 Apr 29. N Engl J Med. 2004. PMID: 15118073 Free article.
Nuclear TARBP2 Drives Oncogenic Dysregulation of RNA Splicing and Decay.
Fish L, Navickas A, Culbertson B, Xu Y, Nguyen HCB, Zhang S, Hochman M, Okimoto R, Dill BD, Molina H, Najafabadi HS, Alarcón C, Ruggero D, Goodarzi H. Fish L, et al. Among authors: okimoto r. Mol Cell. 2019 Sep 5;75(5):967-981.e9. doi: 10.1016/j.molcel.2019.06.001. Epub 2019 Jul 9. Mol Cell. 2019. PMID: 31300274 Free PMC article.
Inactivation of Capicua drives cancer metastasis.
Okimoto RA, Breitenbuecher F, Olivas VR, Wu W, Gini B, Hofree M, Asthana S, Hrustanovic G, Flanagan J, Tulpule A, Blakely CM, Haringsma HJ, Simmons AD, Gowen K, Suh J, Miller VA, Ali S, Schuler M, Bivona TG. Okimoto RA, et al. Nat Genet. 2017 Jan;49(1):87-96. doi: 10.1038/ng.3728. Epub 2016 Nov 21. Nat Genet. 2017. PMID: 27869830 Free PMC article.
Capicua in Human Cancer.
Kim JW, Ponce RK, Okimoto RA. Kim JW, et al. Among authors: okimoto ra. Trends Cancer. 2021 Jan;7(1):77-86. doi: 10.1016/j.trecan.2020.08.010. Epub 2020 Sep 22. Trends Cancer. 2021. PMID: 32978089 Review.
RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer.
Hrustanovic G, Olivas V, Pazarentzos E, Tulpule A, Asthana S, Blakely CM, Okimoto RA, Lin L, Neel DS, Sabnis A, Flanagan J, Chan E, Varella-Garcia M, Aisner DL, Vaishnavi A, Ou SH, Collisson EA, Ichihara E, Mack PC, Lovly CM, Karachaliou N, Rosell R, Riess JW, Doebele RC, Bivona TG. Hrustanovic G, et al. Among authors: okimoto ra. Nat Med. 2015 Sep;21(9):1038-47. doi: 10.1038/nm.3930. Epub 2015 Aug 24. Nat Med. 2015. PMID: 26301689 Free PMC article.
Metastasis: From head to tail.
Okimoto RA, Bivona TG. Okimoto RA, et al. Cell Cycle. 2017 Mar 19;16(6):487-488. doi: 10.1080/15384101.2016.1271636. Epub 2017 Jan 5. Cell Cycle. 2017. PMID: 28055306 Free PMC article. No abstract available.
Functional screening identifies aryl hydrocarbon receptor as suppressor of lung cancer metastasis.
Nothdurft S, Thumser-Henner C, Breitenbücher F, Okimoto RA, Dorsch M, Opitz CA, Sadik A, Esser C, Hölzel M, Asthana S, Forster J, Beisser D, Kalmbach S, Grüner BM, Bivona TG, Schramm A, Schuler M. Nothdurft S, et al. Among authors: okimoto ra. Oncogenesis. 2020 Nov 19;9(11):102. doi: 10.1038/s41389-020-00286-8. Oncogenesis. 2020. PMID: 33214553 Free PMC article.
80 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page